- Parties: The plaintiffs were Bayer Inc., Bayer Healthcare LLC, and Regeneron Pharmaceuticals, Inc. The defendant was Amgen Canada Inc.

- Subject Matter: This action arose under the Patented Medicines (Notice of Compliance) Regulations and concerned competing claims over pharmaceutical patent rights. This case is ongoing.

- Date: The action was discontinued by the plaintiffs, with the consent of the defendant, as of August 18, 2025. This discontinuance was filed in the Toronto office and marks the conclusion of the case unless further proceedings are initiated.

- Venue: This was a federal case before the Federal Court.

- Amount: No financial award was specified.